Latest News

M&As this week: Guanhao Biotech, Cancer Genetics, Alvogen

Chinese biotechnology company Guanhao Biotech plans to acquire a 53.4% stake in two pharmaceutical companies based in China for CNY266m...

M&As this week: Guanhao Biotech, Cancer Genetics, Alvogen

Cancer Research UK and Newcastle University extend drug discovery partnership with Astex

Cancer Research UK and Newcastle University extend drug discovery partnership with Astex

Deals this week: Kadmon Holdings, Antares Pharma, Vicarius Pharma

US-based biopharmaceutical company Kadmon Holdings (Kadmon) has announced a public offering of common stock shares to raise up to $40m in...

Deals this week: Kadmon Holdings, Antares Pharma, Vicarius Pharma

SillaJen and NCI partner to develop new colorectal cancer treatment

SillaJen and NCI partner to develop new colorectal cancer treatment

Hikma and Takeda sign new licensing agreement to expand product portfolio in MENA

Hikma Pharmaceuticals has reached an agreement with Takeda Pharmaceutical Company to expand their licensing and distribution agreement to add new products to its existing portfolio in the...

Hikma and Takeda sign new licensing agreement to expand product portfolio in MENA

Johnson & Johnson and CSIR-IMTECH partner to discover new tuberculosis treatments

Johnson & Johnson’s India-based business has signed a memorandum of understanding (MoU) with the Institute of Microbial Technology (IMTECH) to discover and develop new treatments for...

Johnson & Johnson and CSIR-IMTECH partner to discover new tuberculosis treatments

Evotec buys Aptuit for nearly $300m

German company Evotec has completed the acquisition of Aptuit for a total consideration of approximately $300m to support its long-term strategy to be the industry partner of choice for...

Evotec buys Aptuit for nearly $300m

Shire submits marketing application for lifitegrast to treat dry eye disease in Europe

Shire submits marketing application for lifitegrast to treat dry eye disease in Europe

Amicus’ Galafold receives TGA approval for Fabry disease treatment in Australia

Amicus’ Galafold receives TGA approval for Fabry disease treatment in Australia

Aradigm secures SBIR grant to investigate use of Linhaliq and Lipoquin for PNTM treatment

Aradigm has secured a small business initiative research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health...

Aradigm secures SBIR grant to investigate use of Linhaliq and Lipoquin for PNTM treatment

FDA grants orphan drug status to H3 Biomedicine’s cancer treatment H3B-8800

H3 Biomedicine, a member of Eisai’s global Oncology Business Group, has received orphan drug designation from the US Food and Drug Administration (FDA) for its H3B-8800, a clinical compound used...

FDA grants orphan drug status to H3 Biomedicine’s cancer treatment H3B-8800

Mundipharma acquires global rights for CellAct’s biliary tract cancer treatment CAP7.1

The Mundipharma network of independent associated companies has purchased worldwide development, commercialisation and production rights to CAP7.1 from CellAct for more than...

Mundipharma acquires global rights for CellAct’s biliary tract cancer treatment CAP7.1

Three quarters of CDF treatments now approved on NHS

Three quarters of CDF treatments now approved on NHS

Takeda and Shattuck Labs partner to develop immunotherapies for cancer treatments

Takeda Pharmaceutical has entered a research collaboration with Shattuck Labs to study and develop checkpoint fusion proteins that have the potential to be used as highly differentiated,...

Takeda and Shattuck Labs partner to develop immunotherapies for cancer treatments

Mylan launches three generic anti-retroviral treatments for HIV patients in Canada

Mylan launches three generic anti-retroviral treatments for HIV patients in Canada

SK Capital to buy API business from Perrigo Company

Private investment company SK Capital has signed a new definitive agreement to purchase Perrigo Company’s active pharmaceutical ingredients (API) business, Perrigo...

SK Capital to buy API business from Perrigo Company

Deals this week: BioMarin Pharmaceutical, Spectrum Pharmaceuticals, Orient Pharma

US-based biotechnology company BioMarin Pharmaceutical has announced the completion of an underwritten public offering of senior subordinated convertible notes to raise...

Deals this week: BioMarin Pharmaceutical, Spectrum Pharmaceuticals, Orient Pharma

M&As this week: Sun Pharmaceutical Industries, Northeast Pharmaceutical Group, Mallinckrodt

Sun Pharmaceutical Industries has announced the acquisition of a 15.91% stake in Krystal Biotech for...

M&As this week: Sun Pharmaceutical Industries, Northeast Pharmaceutical Group, Mallinckrodt

WuXi AppTec report shows prospects of immunotherapy treatments for cancer

China-based company WuXi AppTec has published a new report highlighting the prospects of immunotherapy as a potential treatment for...

WuXi AppTec report shows prospects of immunotherapy treatments for cancer

FDA grants orphan drug status to Ocugen’s OCU300 for oGVHD treatment

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for Ocugen’s OCU300 (brimonidine tartrate) to treat patients with ocular graft versus host disease...

FDA grants orphan drug status to Ocugen’s OCU300 for oGVHD treatment

Juniper Pharma and CrystecPharma to create new drug development platform

Juniper Pharma and CrystecPharma to create new drug development platform
cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1460672566_rd1460672566_371857150_ap1460672566_1857678299_946450448